Biopharma Commercial Strategy Consultants Merging the Worlds of Biopharma & Technology

Guys on path, path to market, corval
Susan Nemetz
Sue Nemetz
Founder & CEO

Letter from Our Founder

It has often been said, life experience shapes who you are and where you focus your passions. Growing up in a large family with many siblings and different points of view, I learned early the value of navigating the inevitable day-to-day chaos to get to a place of resolution to keep moving forward!

I have applied this learning in my career, helping biopharma leaders understand that “commercialization is a mindset,” represented by an organization-wide effort to bring their innovative medicines to market.

After decades of work with hundreds of clients, I’ve witnessed the fragmented commercialization planning process and how it bogs down early- to mid-stage companies that have yet to build their internal capabilities.

As an entrepreneur, I knew there has to be a better way.

What if…

At Corval®, we have turned these “what ifs” into a cloud-based commercialization platform that will guide your strategic planning and lead you from the clinic to the market—freeing you up to think bigger and drive innovation for the patients you are committed to serving.

Sue, Signature


Deliver an end-to-end ecosystem that guides biopharma companies through the commercialization process by leveraging decades of strategic commercialization expertise with innovative technology and expert consulting services to deliver a lower-cost, higher-value, single-source solution for long-term success.

The old models for developing a strategic biopharma commercialization plan are fragmented. When companies attempt to do it themselves, the results can vary greatly depending on the experience and expertise of the team. This approach also requires significant resources to update and maintain, with a risk of bias affecting the outcomes. 

Engaging service providers, while potentially beneficial, comes with its own set of challenges as the process is often confusing, time-consuming, and costly. The output from service providers is often a point-in-time assessment that quickly becomes outdated, and it does not build internal capability, making future updates challenging. 

Another option—doing nothing—can result in missing key activities, creating difficulties in catching up later, and increasing the risk that the asset will not meet the needs of the company or patients.

Our Intelligent Platform Offers an Innovative Approach

Biopharma companies and their investors—as well as patients—will benefit from embracing a fresh approach utilizing innovative, cost- and time-saving technology. Using a technology tool for strategic commercialization planning can be more impactful, as it offers ongoing updates and support. 


  • Starts early and takes a broader, more strategic view to make sure you have the right data, talent, and capabilities in place at the right time. This ensures maximum value of your asset can be achieved.
  • Brings decades of commercialization expertise and 75,000+ data points into a sole, elegant interface that provides a single source of truth.
  • Puts the power in your hands—a preliminary pharma commercialization plan is ready to use within hours. 
  • Evolves as data and insights emerge to easily create board/investor reports, onboard new teams, and handle expanding or shifting priorities.

Meet Our Biopharma Commercial Strategy Consultants

We’re a team with big ideas committed to changing the way that innovative therapies get to patients. And we’re growing every day.

Susan Nemetz


Susan is a proven leader and successful entrepreneur in the life science industry. In addition to founding and leading Corval, a novel SaaS platform company, she is the CEO and Founder of The NemetzGroup, a successful, strategic commercialization consultancy. The NemetzGroup has been instrumental in supporting the evolution of over 100 biopharma companies from startup to publicly traded and the development of numerous assets from targets to approved, life-saving treatments. With more than 35 years of corporate strategy, commercial, medical affairs, business development, and operational experience, C-suite leadership teams rely on her thought partnership and mentoring to achieve goals across all stages of drug development.

Prior to launching The NemetzGroup in 2003, Susan served as Vice President, Global Commercial Strategy, and then Vice President of International Commercial Operations at Millennium Pharmaceuticals. Previously, she progressed through multiple commercial leadership roles at DuPont Pharmaceuticals that culminated in her appointment as Executive Vice President of the cardiovascular and imaging franchise. Susan serves as an advisor of Life Science Cares, a collective effort of the life science industry to eliminate the impact of poverty on Boston neighborhoods. Susan received her BS in business management from the University of Minnesota.


Business Analyst

Mairelisa serves as Corval’s Business Analyst, where she coordinates across product and content workflows to support data management, quality analysis, and ongoing product upgrades. Prior to joining Corval, Mairelisa worked for the US Census Bureau, the Mayor's Office of Workforce Development, and the Grand Circle Corporation, where she held a range of responsibilities and gained technical skills in database management, project management, and product and software development. Currently pursuing a BA in Economics at UMass Amherst, Mairelisa enthusiastically continues to support the Corval vision.

Jeff Alexander

head of product

Theodora Bibila

Strategy Lead

Dora joined Corval in 2022 and is our Commercialization Strategy Lead. She is an innovative senior Pharmaceutical/Biotech Executive with deep experience and demonstrated success in leading strategy, product development, and global commercialization with a passion for making a positive impact on patients’ lives and global health.

Most recently, Dora led the cross-functional team responsible for product development and commercialization for the Alzheimer’s Disease product portfolio at Biogen. She directly managed the global commercial team responsible for the development of the strategy and all preparations for the global launch of Aducanumab. Prior to joining Biogen, she was with Merck in roles of increasing responsibility in R&D and marketing at the country, regional, and global level, and has extensive launch experience including several blockbuster brands. She has been instrumental in leading successful strategic partnerships and large public- and private-sector customer contracting and pricing negotiations.

She holds a BS in Chemical Engineering from the Aristotle University of Thessaloniki, Greece, an MS and PhD in Biochemical Engineering from the University of Minnesota, and an MBA from Rutgers Graduate School of Business.

Nigel Cawthon


As a part of the Corval team, Nigel brings over ten years of experience in messaging, prospecting, marketing, account mapping and management, client retention, and more. He has a high-performance history in training new sales associates and an extensive background in managing contracts, proposals, and agreements within the biopharma and healthcare industries. He resides in Indiana where he attended Indiana University and Purdue University. Nigel’s sales and business experience will enable him to become an asset for both current and future clients of Corval.

Melinda Fayette

Director of

Melinda joins Corval as Director of Marketing, where she is responsible for the strategy, development, and execution of marketing, brand, and messaging efforts. She has a proven track record of success in building top-flight systems from the ground-up for start-ups and medium- to enterprise-level organizations specializing in biotech and life sciences. Most recently, Melinda led marketing communications at Cold Chain Technologies, where she executed the successful pivot to provide specialized packaging solutions in response to the COVID-19 pandemic and the CDC’s Operation Warp Speed. Preceding that, she led digital marketing and social media efforts for a variety of life science and consumer product companies. Melinda has a BFA in Graphic Design from the University of Connecticut, School of Fine Arts.

Leon Huggins

software engineer

Leon Huggins is a Software Developer at Corval, where he collaborates with the product team to deliver code that directly affects what the clients see and interact with. Leon's hobbies include graphic design as well as music production and engineering which translate into creative ideas when brainstorming with the product team on future features. Prior to working at Corval, Leon worked in Fintech at Northwestern Mutual as a Frontend developer, after attending Flatiron School where he studied software engineering.

Chris Katsaros

Senior Developer

Chris Katsaros joined Corval in 2024 as a Senior Developer with expertise in software ideation, sales, development, and integration. He is a tech enthusiast with a strong curiosity for the latest trends in software and is highly skilled in both front-end and back-end development for B2B and B2C software features. Chris has a proven track record of working directly with internal and external customers, consistently exceling in translating business needs into scalable software solutions and delivering automation and data insights with measurable success.

In his recent role as a Senior Software Architect at Johnson & Johnson Insurance Agency, Chris created and utilized AI models to estimate profitability, optimized database efficiency, and led the development of a new one-step quoting insurance system.

Born in the Midwest, Chris was drawn to the South by the allure of the ocean and has never looked back—enjoying almost any activity on the water including surfing, fishing, and boating. He has a BAA from the University of North Carolina in Management Information Systems.

Miranda Moriarty

Business Operations

Miranda serves as Corval’s Business Operations Coordinator, with a proven track record of excellence in administrative and leadership roles across diverse industries. Her expertise spans virtual assistance, customer service management, and leadership development. At Corval, she leverages her strong background in coordination and team management to enhance operational efficiencies and support business growth. Miranda's commitment to excellence and her ability to thrive in dynamic environments make her a key asset to the Corval team.

Allison Murphy

Head of Growth
and channel sales

Allison Murphy joined Corval in 2024 as the Head of Growth and Channel Sales to lead the growth and market expansion of Corval. Allison has extensive life sciences experience and expertise in technology with depth and breadth in the enterprise and software sales environment. Her most recent executive sales positions were President of Strategic Partnerships and Consulting at POCN, an educational community dedicated to PAs and NPs, Managing Director of Life Sciences at Curate Insights, US Director of Veeva Link, and VP of Business Development Commercial Solutions at Syneos Health. Prior to these roles, she spent ten years at Lilly in customer-facing roles in sales and medical affairs. She began her professional training as a Nurse Clinician in academic centers

Allison’s previous experiences demonstrate her unique talents as a strategic thinker and compassionate leader. She has a proven track record in leading high-performing sales teams, developing effective go-to-market strategies across multiple segments, and cultivating strong relationships with key stakeholders in the biopharmaceutical sector. Allison holds a Bachelor of Nursing from Villanova University.

Johanna Power

Head of Finance
and operations

Casey Ryan

Product Manager

Casey joins Corval as a Product manager where she is responsible for building and driving the implementation of the product roadmap. Casey first joined Corval in 2020 as a business analyst, in this role she oversaw the implementation of Corval’s many data sets. She then became Junior Project Manager in 2021, further honing her skill in the product before moving into the role of Product manager in 2023. Prior to joining Corval, Casey was a Corps Support Intern at City Year Boston, where she managed events and seminars for incoming members and external partners. Casey also served as a Public Affairs Intern at Planned Parenthood of Northern New England, where she assisted in a research study in collaboration with Duke University to determine the effectiveness of deep-canvassing initiatives. Casey is a recent graduate from Hamilton College, where she earned a BA in Government and Hispanic Studies. She is also a proud alum of NOLS, where she bravely led a team expedition through the Yukon, CA wilderness.

Radhika Sabnis

Associate Director
Customer &
Partner Success

Radhika Sabnis joined Corval in 2022 as a Customer Coordinator where she is responsible for overseeing all project activities related to onboarding customers. She has several years of project management experience in the biopharma and healthcare domain and has led complex workstreams spanning software implementation, manufacturing, operations, and quality and process improvement. In her recent position with Healthcentric Advisors, she worked with hospital systems and clinicians throughout Massachusetts to maintain healthcare quality compliance, streamline workflows, and maximize Medicare payments. She has held similar management and consulting roles at Partners HealthCare, Exeter Health Resources, and Lonza Biologics. In addition to her PMP certification, Radhika holds an MS in Genetic Engineering from Bangalore University and an MBA from the University of New Hampshire.


Business Operations

Lindsay serves as the Director of Business Operations, where she is responsible for coordinating cross-functional activities and operational logistics.

She has over 15 years of experience in executive administration and event coordination, supporting teams to streamline workflows and ensure business goals are achieved. Most recently, Lindsay was the Conference Center Manager at Berkshire Partners, where she oversaw execution of more than 800 investor events annually. Preceding that, she was a Marketing Assistant at Jefferies Financial Group, where she supported timely execution of sales and marketing campaigns. Lindsay earned her BA in communications from Keene State College.

Michelle Xie

Business Analyst

Michelle Xie is a Business Analyst at Corval where she assists with market research, data analysis, documentation, and process improvement. She first joined Corval in 2022 as a Product and Platform Intern, assisting with developing feature roadmaps and defining milestones. From there, she moved into a Business Operations Intern role where she worked closely with the Director of Business Operations to coordinate operational logistics and activities on a day-to-day basis. Prior to joining Corval, she was a Marketing Intern at Living in Freedom Together.

Michelle has a BA in Management and is a recent MBA graduate with a concentration in Information Management and Business Analytics from Clark University.

We couldn't do it without the help of our product and development partners.

byrd-alley logo
Tech-CXO Logo

Join Us

We are a small and mighty team building a product at the exciting intersection of biopharma and technology.

We value our customers, our partners, and our people. We believe in a culture of learning, collaboration, empathy, and diversity. We believe that work and life should be in balance and that striving for excellence can co-exist with striving for happiness. If you are interested in helping us build this innovative company, learning a lot, and having fun while doing it, we’d love to hear from you. 

Email us at

Follow us on LinkedIn.


Schedule a conversation with our commercialization expert to understand your options.

Corval is aligned with the Life Science Cares mission to make a meaningful impact on poverty by harnessing the resources of the life sciences industry. As a sign of our commitment, we are donating a portion of sales to Life Science Cares.

We use cookies to improve user experience and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By using this website you consent to store on your device all the technologies described in our Privacy Policy.